Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurex Corporation -- Ignore unavailable to you. Want to Upgrade?

To: Cody Goebel who wrote (434)	4/30/1998 1:21:00 AM
From: cl	Read Replies (2) \| Respond to of 449

From the press release, it seems like the merger approval will give us 31 bucks a piece regardless of market condition. Am I correct? If so, nxco should go higher right? I never been through a merger stock, do I actually need to sell it at 31 to get Elan shares in return? I was hoping nxco could push through 111 themselves to capitalize on this blockbuster. Now with Elan coming to picture, I am not too sure. In other words, 111 would have much greater effect on nxco as an independent company than part of Elan. Very tempted to get out... cl